SYLVIA RODRIGUEZ: Open Payments
NPI 1053859728 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 11 payments from 10 companies in 2025. Trend: 2023 $837 · 2024 $866 · 2025 $317
Food & beverage: $186Education: $131
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $100 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| PFIZER INC. | 1 | $31 |
| TAIHO ONCOLOGY, INC. | 1 | $26 |
| Boston Scientific Corporation | 1 | $26 |
| Eisai Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Gilead Sciences, Inc. | 1 | $16 |
Products named: IBRANCE, LONSURF, TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial), Lenvima, Tecentriq Hybreza, VENCLEXTA, BLENREP, KEYTRUDA.
Industry payments across TX — which companies pay providers there.
